| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cadrenal Therapeutics, Inc. (CVKD) has 3 insiders with recent SEC Form 4 filings, including 1 buy and 0 sells. CVKD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 128.6K | $387.1K | -4,778 | |
| Dir | 5.0K | $15.0K | - | |
| CFO | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 16, 2023 | Murphy John Raymond50 | Director | Buy | 20,000 | $1.67 | $33,398.00 | +3.6% | +7.2% | -60.6% |